|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300070757 |
|
最近更新日期: Date of Last Refreshed on: |
2023-04-23 09:14:36 |
|
注册时间: Date of Registration: |
2023-04-23 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
中文版不孕症自我效能量表临界值研究 |
|
Public title: |
Study on the critical value of Chinese version of Infertility Self-Efficacy Scale |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
中文版不孕症自我效能量表临界值研究 |
|
Scientific title: |
Study on the critical value of Chinese version of Infertility Self-Efficacy Scale |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
孟盈 |
研究负责人: |
文宏贵 |
|
Applicant: |
Meng Ying |
Study leader: |
Wen, honggui |
|
申请注册联系人电话: Applicant telephone: |
+86 19922171433 |
研究负责人电话:
Study leader's |
+86 13752876394 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
yingmengym@outlook.com |
研究负责人电子邮件: Study leader's E-mail: |
356727212@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
重庆市渝中区金汤街64号 |
研究负责人通讯地址: |
重庆市渝中区金汤街64号 |
|
Applicant address: |
No. 64, Jintang Street, Yuzhong District, Chongqing |
Study leader's address: |
No. 64, Jintang Street, Yuzhong District, Chongqing |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
重庆医科大学附属妇女儿童医院 |
||
|
Applicant's institution: |
Women and Children's Hospital of Chongqing Medical University |
||
|
研究负责人所在单位: |
重庆医科大学附属妇女儿童医院 |
||
|
Affiliation of the Leader: |
Women and Children's Hospital of Chongqing Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2022-RGI-09 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
重庆市妇幼保健院人类辅助生殖技术临床应用与伦理委员会 |
||
|
Name of the ethic committee: |
Clinical Application and Ethics Committee of Human Assisted Reproductive Technology in Chongqing Women and Children's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-09-06 00:00:00 | ||
|
伦理委员会联系人: |
王兴林 |
||
|
Contact Name of the ethic committee: |
Wang, Xinglin |
||
|
伦理委员会联系地址: |
重庆市渝北区龙山街道龙山路120号 |
||
|
Contact Address of the ethic committee: |
No. 120, Longshan Road, Longshan Street, Yubei District, Chongqing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 18883137017 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
重庆医科大学附属妇女儿童医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Women and Children's Hospital of Chongqing Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
重庆市渝中区金汤街64号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 64, Jintang Street, Yuzhong District, Chongqing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
无 |
||||||||||||||||||||||
|
Source(s) of funding: |
Not available |
||||||||||||||||||||||
|
研究疾病: |
不孕症 |
||||||||||||||||||||||
|
Target disease: |
infertility |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
针对我国不孕症患者自我效能得分进行临界值分析,以期更准确的筛选出依从性行为匮乏的高危个体 |
||||||||||||||||||||||
|
Objectives of Study: |
To determine the cut-off point of Chinese version of Infertility Self-efficacy Scale (CISE) in infertile women |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①符合 WHO 不孕症诊断要求,即有正常性生活且未采取任何避孕措施的育龄期夫妇同 居 1 年或以上而未妊娠或不能维持妊娠者; ②18 kg/m2 <BMI<24.0 kg/m2; ③自愿参加本研究; ④卵巢功能储备正常; ⑤有一定听说读写能力 |
||||||||||||||||||||||
|
Inclusion criteria |
①women who were diagnosed infertility
②18 kg/m2 |
||||||||||||||||||||||
|
排除标准: |
① 做人工授精助孕的女性; ② 门诊监测排卵的患者; ③ 精神疾病或慢性疾病的患者 |
||||||||||||||||||||||
|
Exclusion criteria: |
① women who underwent intrauterine insemination; ② Outpatient monitoring ovulation induction; ③ women with mental disease or chronic diseases |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-03-01 00:00:00至 To 2023-08-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-05-01 00:00:00 至 To 2023-05-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
问卷星 https://www.wjx.cn/vm/eGyto4d.aspx# |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
https://www.wjx.cn/newwjx/manage/myquestionnaires.aspx?randomt=1675395256 |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
网络调查问卷的形式进行数据采集;使用个人账号和密码进入网络平台系统进行数据管理 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Collect data in the form of online questionnaire; Use personal account and password to access the network platform system for data management |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |